The immunoblotting analysis showed that TAS-116 treatment induced HSP70 expression, an indicator of HSP90 inhibition, in GIST T1, R8, R9 and R2 cells. This evidence concerns the gene HSP90AA1 and gastrointestinal stromal tumor.